SkinHealth Systems Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
SKIN$15.94-4.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands, except for share and per share amounts)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Net sales | $69,171 | $70,655 | $206,194 | $218,422 |
| Cost of sales | 22,024 | 25,021 | 65,270 | 75,096 |
| Gross profit | 47,147 | 45,634 | 140,924 | 143,326 |
| Operating expenses: | ||||
| Selling and marketing | 20,008 | 20,928 | 64,221 | 70,077 |
| Research and development | 1,662 | 1,698 | 4,171 | 3,947 |
| General and administrative | 20,499 | 29,250 | 65,783 | 90,267 |
| Total operating expenses | 42,169 | 51,876 | 134,175 | 164,291 |
| Income (loss) from operations | 4,978 | (6,242) | 6,749 | (20,965) |
| Interest expense | 6,271 | 6,311 | 18,912 | 12,953 |
| Interest income | (1,394) | (1,256) | (4,169) | (7,442) |
| Other income, net | (33) | (601) | (1,096) | (18,807) |
| Change in fair value of warrant liabilities | — | (210) | — | (349) |
| Foreign currency transaction loss (gain), net | 242 | 159 | 1,485 | (6,190) |
| Loss before provision for income taxes | (108) | (10,645) | (8,383) | (1,130) |
| Income tax expense | 780 | 386 | 1,804 | 285 |
| Net loss | (888) | (11,031) | (10,187) | (1,415) |
| Comprehensive (loss) income, net of tax: | ||||
| Foreign currency translation adjustments | (323) | 421 | (288) | 5,178 |
| Comprehensive (loss) income | $(1,211) | $(10,610) | $(10,475) | $3,763 |
| Net loss per share | ||||
| Basic | $(0.14) | $(1.74) | $(1.58) | $(0.22) |
| Diluted | $(0.14) | $(1.74) | $(1.58) | $(2.12) |
| Weighted average common stock outstanding | ||||
| Basic | 6,510,178 | 6,345,283 | 6,460,831 | 6,301,728 |
| Diluted | 6,510,178 | 6,345,283 | 6,460,831 | 6,865,390 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.